Literature DB >> 11490929

Anatomical basis of lumboscopy.

R Yiou1, V Delmas, D Chopin, C C Abbou.   

Abstract

Lumboscopy provides an approach to the retroperitoneum for the majority of upper urinary tract operations. The technique involves a knowledge of specific anatomical landmarks that differ from those in classical open surgery, because of the inferior approach to the renal pedicle with the kidney initially mobilized in a ventral and cranial position. An anatomical study was conducted on five cadavers, using images from surgical operations, in order to describe the vascular elements of the retroperitoneal spaces as they are approached during lumboscopy, as well as to define specific anatomical landmarks. Identification of psoas major is crucial as it is then possible to locate the renal pedicle opposite and the area of the great vessels medially. During dissection of the renal pedicle the renal vein and its branches are the first elements to be approached. On the left side the distal portion of the renal vein can be confused with a reno-hemi-azygo-lumbar trunk, due to the initial ventral mobilization of the kidney stretching it. Because of the inferior view of the renal pedicle the reno-hemi-azygo-lumbar trunk can obscure part of the renal artery and may be confused with the renal vein. On the right side initial identification of the inferior vena cava on the medial aspect of psoas major facilitates identification of the gonadal, renal and suprarenal veins all located in the same plane.

Entities:  

Mesh:

Year:  2001        PMID: 11490929     DOI: 10.1007/s00276-001-0179-7

Source DB:  PubMed          Journal:  Surg Radiol Anat        ISSN: 0930-1038            Impact factor:   1.246


  1 in total

1.  Analysis of complications from 600 retroperitoneoscopic procedures of the upper urinary tract during the last 10 years.

Authors:  Dimitri Liapis; Alexandre de la Taille; Guillaume Ploussard; Grégoire Robert; Laurence Bastien; Andras Hoznek; Dimitri Vordos; Claude Abbou; Laurent Salomon
Journal:  World J Urol       Date:  2008-09-19       Impact factor: 4.226

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.